MTOR and prostate carcinoma: This rise in glyoxalase enzymes is facilitated by the activation of the PI3K/AKT/mTOR pathway through the PI3K/AKT/mTOR/p-PKM2(Y105)/ERa axis, ultimately propelling prostate cancer progression [82].